Small-vessel vasculitis

Dermatologic Therapy

Volumn 25, Issue 2, 2012, Pages 148-157

  Kinney, Megan A ^a   Jorizzo, Joseph L ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cutaneous small vessel vasculitis; Henoch Sch nlein; Leukocytoclastic vasculitis

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DAPSONE; HYDANTOIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INDOMETACIN; INSULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PHENOTHIAZINE; PREDNISONE; QUININE; RIBAVIRIN; RITUXIMAB; TETRACYCLINE DERIVATIVE; THALIDOMIDE; UNINDEXED DRUG;

ACUTE HEMORRHAGIC EDEMA OF INFANCY; ANAPHYLACTOID PURPURA; BACTERIAL SKIN DISEASE; COMPRESSION THERAPY; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; ERYTHEMA; ERYTHEMA ELEVATUM DIUTINUM; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LEUKOCYTOCLASTIC VASCULITIS; NEOPLASM; PATHOGENESIS; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; REVIEW; SKIN BIOPSY; SKIN DEFECT; SKIN EDEMA; SKIN ULCER; SMALL VESSEL VASCULITIS; SYSTEMIC DISEASE; URTICARIA; URTICARIAL VASCULITIS; VASCULITIS; VENULE;

BLOOD VESSELS; HUMANS; SEVERITY OF ILLNESS INDEX; SKIN; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 84862568327     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01535.x     Document Type: Review

References (47)

1. Chung L, Kea B, Fiorentino DF. Cutaneous vasculitis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology, 2nd ed. St. Louis: Mosby, 2008: 347-367.
2. Barham KL, Jorizzo JL, Grattan B, Cox NH. Vasculitis and neutrophilic vascular reactions. In: Burns DA, Breathnack S, Cox N, Griffiths C, eds. Rook's textbook of dermatology, 2004: 49.1-49.32.
3. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005: 27 (6): 504-528. (Pubitemid 44383995)
4. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008: 9 (2): 71-92. (Pubitemid 351280952)
5. Xu LY, Esparza EM, Anadkar MJ, Crone KG, Brasington RD. Cutaneous manifestations of vasculitis. Semin Arthritis Rheum 2009: 38: 348-360.
6. Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 2004: 17: 56-61. (Pubitemid 40075648)
7. Grzeszkiewicz TM, Fiorentino DF. Update on cutaneous vasculitis. Semin Cutan Med Surg 2006: 25: 221-225. (Pubitemid 44894974)
8. Eleftheriou D, Brogan PA. Vasculitis in children. Best Pract Res Clin Rheumatol 2009: 23 (3): 309-323.
9. Saulsbury F. Clinical update: Henoch-Schönlein purpura. Lancet 2007: 369: 976-978.
10. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, Flageul B, Morel P, Rybojad M. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997: 133: 438-442.
11. Pillebout E, Thervet E, Hill G, Albert C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002: 13 (5): 1271-1278. (Pubitemid 34441408)
12. Mutsui H, Shibagaki N, Kawanura T, Matsui H, Shimada S. A clinical study of Henoch-Schönlein purpura associated with malignancy. J Eur Acad Dermatol Venereol 2009: 23: 394-401.
13. Poyrazoglu HM, Per H, Gunduz Z, et al. Acute hemorrhagic edema of infancy. Pediatr Int 2003: 45 (6): 697-700. (Pubitemid 38130364)
14. Di Lernia V, Lombardi M, Lo Scocco G. Infantile acute hemorrhagic edema and rotavirus infection. Pediatr Dermatol 2004: 21: 548-550. (Pubitemid 39363172)
15. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheum 2006: 18: 54-63. (Pubitemid 43740406)
16. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinemia vasculitis. Curr Opin Rheum 2002: 14: 29-35. (Pubitemid 34059886)
17. Davis MD, Brewer JD.Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004: 24 (2): 183-213. (Pubitemid 38553747)
18. Gibson LE, el-Azhary RA. Erythema elevatum diutinum. Clin Dermatol 2000: 18 (3): 295-299. (Pubitemid 30336508)
19. Aldave AJ, Shih JL, Jovkar S, McLeod SD. Peripheral keratitis associated with erythema elevatum diutinum. Am J Ophthalmol 2003: 135 (3): 389-390. (Pubitemid 36279531)
20. Mitamura Y, Fujiwara O, Miyanishi K, Sato H, Saga K, Ohtsuka K. Nodular scleritis and panuveitis with erythema elevatumdiutinum. Am J Ophthalmol 2004:137(2): 368-370. (Pubitemid 38221023)
21. Sais G, Vidaller A, Jucgla A, Gallardo F, Peyri J. Cochicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol 1995: 131: 1399-1402.
22. Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1985: 13 (2 Pt 1): 193-200. (Pubitemid 15007110)
23. Fredenberg M, Malkinson F. Sulfone therapy in the treatment of leukocytoclastic vasculitis: a report of 3 cases. J Am Acad Dermatol 1986: 16: 772-778.
24. Katz S, Gallin J, Hertz K, et al. Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies, and successful treatment with dapsone. Medicine 1977: 56: 443-455. (Pubitemid 8195313)
25. Goon AT, Tay YK, Giam YC, Lau TC, Chan HL. An unusual case of cutaneous vasculitis. Ann Acad Med Singapore 2000: 29 (2): 249-252.
26. Zargari O. Pentoxifylline: a drug with wide spectrum applications in dermatology. Dermatol Online J 2008: 14 (11): 2.
27. Jorizzo JL, White WL, Wise CM, Zanolli MD, Sheretz EF. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991: 24 (6 Pt 1): 973-978.
28. Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008: 359 (26): 2790-2803.
29. Cem Ar M, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma. Ann Hematol 2005: 84 (9): 609-613. (Pubitemid 41194550)
30. Stassen PM, Tervaert JW, Stegeman CA. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 2007: 66 (6): 798-802. (Pubitemid 46846700)
31. Hiemstra TF, Walsh M, Mahr A, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 2010: 304 (21): 2381-2388.
32. Plotkin GR, Patel BR, Shah VN. Behçet's syndrome complicated by cutaneous leukocytoclastic vasculitis. Response to prednisone and chlorambucil. Arch Intern Med 1985: 145 (10): 1913-1915. (Pubitemid 16221752)
33. Kalliakmani P, Benou E, Goumenos DS. Cyclosporin A in adult patients with Henoch-Schönlein purpura nephritis and nephrotic syndrome: 5 case reports. Clin Nephrol 2011: 75 (4): 380-383.
34. Park JM, Won SC, Shin JI, Yim H, Pai KS. Cyclosporin a therapy for Henoch-Schönlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 2011: 26 (3): 411-417.
35. Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum 2011: 41 (1): 61-70.
36. Roccatello D, Sciascia S, Rossi D, et al. Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. Am J Nephrol 2011: 34 (2): 175-180.
37. Roccatello D, Baldovino S, Rossi D, et al. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol 2008: 34 (1): 111-117.
38. Mukhtyar C, Misbah S, Wilkinson J, Wordsworth P. Refractory urticarial vasculitis responsive to anti-B-cell therapy. Br J Dermatol 2009: 160 (2): 470-472.
39. Kalsch AI, Schmitt WH, Breedijk A, et al. In vivo effects of cyclic adinistration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis. Clin Exp Immunol 2006: 146 (3): 455-462. (Pubitemid 44722164)
40. El Khayat HR, Fouad YM, Ahrmad EA, El Amin H, Ismael F, Rizk A. Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment. Hepatol Int 2011 Aug 19. [Epub ahead of print].
41. Pietrogrande M, De Vita S, Zignego AL, et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011: 10 (8): 444-454.
42. Cooper CL, Druyts E, Thorlund K, et al. Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis. Ther Clin Risk Manag 2012: 8: 105-130.
43. Sneller MC, Hu Z, Langford CA. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C-associated cryoglobulinemic vasculitis. Arthritis Rheum 2012: 64 (3): 835-842.
44. De Vita S, Quartuccio L, Isola M, et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012: 64 (3): 843-853.
45. Di Maria MV, Hollister R, Kaufman J. Case report: severe microscopic plyangiitis successfully treated with extracorporeal membrane oxygenation and immunosupression in a pediatric patient. Curr Opin Pediatr 2008: 20 (6): 740-742.
46. Shah D, Rowbottom AW, Thomas CL, Cumber P, Chowdhury MM. Hypocomplementaemic urticarial vasculitis associated with non-Hodgkin lymphoma and treatment with intravenous immunoglobulin. Br J Dermatol 2007: 157 (2): 392-393. (Pubitemid 47083838)
47. Yamazaki-Nakashimada MA, Duran-McKinster C, Ramirez- Vargas N, Hernandez-Bautista V. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol 2009: 26 (4): 445-447.